Stock 4151 KYOWA KIRIN CO. LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Consensus Kyowa Kirin Co. Ltd.

Equities

4151

JP3256000005

Delayed Japan Exchange
Other stock markets
 02:00:00 2024-05-02 am EDT 		5-day change 1st Jan Change
2,668 JPY 0.00% Intraday chart for Kyowa Kirin Co. Ltd. +0.45% +12.55%
May. 02 BridgeBio Pharma Shares Decline After Q1 Financial Results MT
Apr. 08 U.S. FDA declines to approve Supernus' drug-device combination for Parkinson's disease RE

Evolution of the average Target Price on Kyowa Kirin Co. Ltd.

Price target over the last 5 years

History of analyst recommendation changes

95b51f.BQXA8jM8X8IiN-6A47o6pe31byQimhkOVQ6rCd53-i4.QkCDolhaELpAWa2w0YNdkKmzCEtbq09pMDmaRoY6g1d0Z4HfaVQ2jxFthQ~3dd76064c07a45836ecc69a69afc3198

Analyst Recommendations on Kyowa Kirin Co. Ltd.

Jefferies Adjusts Kyowa Kirin’s Price Target to 3,000 Yen From 3,600 Yen, Keeps at Buy MT
Jefferies Adjusts Kyowa Kirin's Price Target to 3,600 Yen From 3,900 Yen, Keeps at Buy MT
Nikkei 225 Down 1.5% on ECB Rate Hike, US CPI Outlook MT
MEI Pharma Says Treatment With Follicular Lymphoma Drug Candidate Shows Complete Response Rate of Over 35% in Mid-Stage Trial MT
Kyowa Hakko Kirin Co., Ltd. Provides Tax Rate Outlook for the Year 2018 CI
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
12
Last Close Price
2,668 JPY
Average target price
3,050 JPY
Spread / Average Target
+14.34%
High Price Target
3,800 JPY
Spread / Highest target
+42.46%
Low Price Target
2,500 JPY
Spread / Lowest Target
-6.28%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Kyowa Kirin Co. Ltd.

Jefferies & Co.

Ratings for Kyowa Kirin Co. Ltd.

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. 4151 Stock
  4. Consensus Kyowa Kirin Co. Ltd.